Document is current
Any future updates will be listed below
-
Authors
Straub, B. K. https://orcid.org/0000-0002-4857-1561
Dries, V.
Breuhahn, K.
Kasper, H. U.
Drebber, U.
Berger, I.
Mittler, J.
Roth, W.
Weinmann, A.
Dienes, H. P.
Schirmacher, P.
-
Funding
Funding for this research was provided by:
Bundesministerium für Forschung, Technologie und Raumfahrt (e:Bio_MS_DiLi)
Bundesministerium für Forschung, Technologie und Raumfahrt (FKZ 031L0074H)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- License Information
-
More Information
Article History
Received: 21 December 2025
Revised: 26 February 2026
Accepted: 22 March 2026
First Online: 8 April 2026
Declarations
:
: The investigation was approved by the local ethical committees of the University of Cologne, University Hospital Heidelberg (205/2005 and 206/2006) and University Medicine Mainz/Landesärztekammer Rhineland-Palatinate (837.360.16 (10679)).
: No patient consent was obtained as data analysis was retrospective in nature, anonymous and no identifying images or informations are shown.
: The work was supported in part by a grant of the Federal Ministry of Education and Research BMBF to KB (e:Bio_MS_DiLi; FKZ 031L0074H).
: VD has accepted fees for speaking and for writing about the histopathology of hepatitis C at two conferences and the website from Hofmann La Roche, main producer of phenprocoumon (Marcumar © ). PS has received speaker and consultation fees from Hofmann La Roche on other topics. BKS has received speaker and consultation fees from Bayer Healthcare, Bristol Myers Squibb, Boehringer Ingelheim, Astra Zeneca, med update as well as IMPP and holds a scientific cooperation with Resolve Biosciences, but not on the topic of drug-induced liver injury. All other authors declare no conflict of interest.
